Recordati Industria Chimica e Farmaceutica S.p.A. (LON:0KBS)

Market Cap	8.45B -15.2%
Revenue (ttm)	2.23B +12.6%
Net Income	352.98M -4.4%
EPS	1.69 -4.4%
Shares Out	n/a
PE Ratio	23.93
Forward PE	14.44
Dividend	1.12 (2.34%)
Ex-Dividend Date	Nov 24, 2025

Volume	42,238
Average Volume	49,255
Open	48.07
Previous Close	47.82
Day's Range	47.42 - 47.82
52-Week Range	44.04 - 60.95
Beta	0.61
RSI	48.72
Earnings Date	Feb 17, 2026

About LON:0KBS

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops REC 0545 for acute decompensation in maple syrup urine diseases; Isturia for endogenous Cushing’s syndrome; Cystadrops for corneal cystine crystal deposits; Carbaglu for hyperammonemia due ...

• Industry: Pharmaceutical Preparations
• Founded: 1926
• Employees: 4,583
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0KBS

Financial Performance

In 2024, LON:0KBS's revenue was 2.34 billion, an increase of 12.45% compared to the previous year's 2.08 billion. Earnings were 416.51 million, an increase of 7.01%.

Financial numbers in EUR